<unk>  is a dopamine receptor agonist that is FDA approved for the {{{indicationType}}} of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas.   Common adverse reactions include constipation, nausea, dizziness, headache and fatigue.
Cabergoline
Metergoline
Methysergide
Methylergonovine 
Brexanolone
Eluxadoline
Terguride
Allylestrenol